Windtree Therapeutics - Stock Price History | WINT

Historical daily share price chart and data for Windtree Therapeutics since 2021 adjusted for splits. The latest closing stock price for Windtree Therapeutics as of September 24, 2021 is 1.89.
  • The all-time high Windtree Therapeutics stock closing price was 216.62 on April 19, 2016.
  • The Windtree Therapeutics 52-week high stock price is 8.75, which is 363% above the current share price.
  • The Windtree Therapeutics 52-week low stock price is 1.58, which is 16.4% below the current share price.
  • The average Windtree Therapeutics stock price for the last 52 weeks is 3.81.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Windtree Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 5.1169 2.4365 9.9000 0.8121 5.1300 110.55%
2019 2.4365 2.4365 2.4365 2.4365 2.4365 0.00%
2018 2.4365 2.4365 2.4365 2.4365 2.4365 0.00%
2017 56.9651 76.2076 101.4101 2.4365 2.4365 -96.75%
2016 126.9848 216.6217 216.6217 73.8074 75.0075 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.051B $0.000B
Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71